Journal Article

DKFZ-2022-02421

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.

Arndt, V. (First author)DKFZ* ; Doege, D. (First author)DKFZ* ; Fröhling, S.DKFZ* ; Albers, P. ; Algül, H. ; Bargou, R. ; Bokemeyer, C. ; Bornhäuser, M. ; Brandts, C. H. ; Brossart, P. ; Brucker, S. Y. ; Brümmendorf, T. H. ; Döhner, H. ; Gattermann, N. ; Hallek, M. ; Heinemann, V. ; Keilholz, U. ; Kindler, T. ; von Levetzow, C. ; Lordick, F. ; Neumann, U. P. ; Peters, C. ; Schadendorf, D. ; Stilgenbauer, S. ; Zander, T. ; Zips, D. ; Braun, D.DKFZ* ; Seufferlein, T. ; Nettekoven, G. ; Baumann, M. (Last author)DKFZ*

2023
Springer Berlin

This record in other databases:  

Please use a persistent id in citations: doi:10.1007/s00432-022-04407-1

Abstract: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic.Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022.The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (- 21%) and psycho-oncologic care (- 12%), but also tumor surgery (- 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care.This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.

Keyword(s): Aftercare ; Comprehensive cancer centers ; Early diagnosis of cancer ; SARS-CoV-2 infection ; Treatment delays

Note: #EA:C071#EA:C070#LA:E220# / 2023 Feb;149(2):913-919

---

Contributing Institute(s):

1. C071 Cancer Survivorship (C071)
2. C070 Klinische Epidemiologie und Alternf. (C070)
3. Translationale Medizinische Onkologie (B340)
4. E220 Radioonkologie Radiobiologie (E220)

Research Program(s):

1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)

Appears in the scientific report 2022

---

Database coverage:
; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF < 5 ; JCR ; SCOPUS ; Web of Science Core Collection

---